SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021247
Filing Date
2023-05-11
Accepted
2023-05-11 16:12:45
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alxo-20230331.htm   iXBRL 10-Q 2761412
2 EX-10.1 alxo-ex10_1.htm EX-10.1 54092
3 EX-31.1 alxo-ex31_1.htm EX-31.1 20741
4 EX-31.2 alxo-ex31_2.htm EX-31.2 20978
5 EX-32.1 alxo-ex32_1.htm EX-32.1 11498
6 EX-32.2 alxo-ex32_2.htm EX-32.2 11491
  Complete submission text file 0000950170-23-021247.txt   9204478

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxo-20230331_def.xml EX-101.DEF 141939
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxo-20230331_lab.xml EX-101.LAB 425314
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxo-20230331_pre.xml EX-101.PRE 288491
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxo-20230331_cal.xml EX-101.CAL 55211
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxo-20230331.xsd EX-101.SCH 51355
63 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20230331_htm.xml XML 1790639
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 23911151
SIC: 2834 Pharmaceutical Preparations